29. Monitoring and Management of Hepatitis B, Hepatitis C, and HIV Infection before and after Transplantation

  1. Bipin N Savani MD
  1. Keith Luckett and
  2. Stephen Dummer

Published Online: 6 SEP 2013

DOI: 10.1002/9781118473306.ch29

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

How to Cite

Luckett, K. and Dummer, S. (2013) Monitoring and Management of Hepatitis B, Hepatitis C, and HIV Infection before and after Transplantation, in Blood and Marrow Transplantation Long-Term Management: Prevention and Complications (ed B. N. Savani), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118473306.ch29

Editor Information

  1. Professor of Medicine,Director, Long Term Transplant Clinic, Hematology and Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, TN, USA

Author Information

  1. Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville TN, USA

Publication History

  1. Published Online: 6 SEP 2013
  2. Published Print: 1 OCT 2013

ISBN Information

Print ISBN: 9781118473405

Online ISBN: 9781118473306

SEARCH

Keywords:

  • stem cell transplantation;
  • hepatitis B virus;
  • hepatitis C virus;
  • human immunodeficiency virus;
  • hepatitis B surface antigen;
  • interferon;
  • ribavirin;
  • antiretroviral agents

Summary

Hepatitis B virus, hepatitis C virus, and human immunodeficiency virus are human pathogens that have immense global impact beyond the realm of transplantation. Each virus also has a very complex biology, and the antiviral management of the viruses requires a high level of expertise and familiarity with an ever-expanding list of antiviral medications. The scope of this chapter only allows for a basic introduction. It offers a general approach to thinking about the detection of these viruses and their treatment in the stem cell transplant setting. The transplant practitioner is advised to read beyond the information presented here and seek advice and consultation from experts in each of the viral infections in the design of specific protocols for screening, monitoring, and prevention.